MedTrace Logo

A Non-interventional Registry for Patients with Hepatitis B Virus Infection

NCT05051098 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-03-13

No results posted yet for this study

Summary

In order to tackle the unmet needs in chronic HBV infection, a consortium of clinical partners has gathered to establish a registry for patients with hepatitis B mono- and co-infections. The partners will build up a European-wide registry to be able to stratify patients for upcoming clinical trials.

Extensive analyses of virus and host-specific parameters are to be carried out from these patients. The knowledge gained thereby should contribute to a better understanding of the HBV control and enable patient stratification with regard to immunomodulatory therapies.

Furthermore, hepatitis B patients are to be identified who are willing to participate in future studies to investigate immunotherapies to cure HBV infections (e.g. therapeutic vaccines).

Conditions

  • Hepatitis B Virus Infection

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • European Union

    collaborator OTHER

  • German Center for Infection Research

    collaborator OTHER

  • German Liver Foundation (DLS)

    collaborator UNKNOWN

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Markus Cornberg · Hannover Medical School

  • Xavier Forns · Fundacio Clinic per a la Recerca Biomedica

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-06
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05051098 on ClinicalTrials.gov